Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats
- PMID: 16723681
- DOI: 10.1373/clinchem.2006.068577
Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats
Abstract
Background: Cell-free DNA circulating in blood is a candidate biomarker for malignant tumors. Unlike uniformly truncated DNA released from apoptotic nondiseased cells, DNA released from dead cancer cells varies in size. We developed a novel method to measure the ratio of longer to shorter DNA fragments (DNA integrity) in serum as a potential biomarker for patients with colorectal cancer (CRC) or periampullary cancers (PACs).
Methods: Sera from 32 patients with CRC (3 stage I, 14 stage II, 6 stage III, and 9 stage IV patients), 19 patients with PACs (2 stage I, 9 stage II, 1 stage III, and 7 stage IV patients), and 51 healthy volunteers were assessed by quantitative real-time PCR of ALU repeats (ALU-qPCR) with 2 sets of primers (115 and 247 bp) amplifying different lengths of DNA. We used serum directly as a template for ALU-qPCR without DNA purification. DNA integrity was determined as ratio of qPCR results of 247-bp ALU over 115-bp ALU.
Results: ALU-qPCR had a detection limit of 0.01 pg of DNA. Eliminating DNA purification reduced technical artifacts and reagent/labor costs. Serum DNA integrity was significantly increased for stage I/II and III/IV CRC and stage I/II and III/IV PACs (P = 0.002, P = 0.006, P = 0.022, and P <0.0001, respectively). ROC curves for detecting CRC and PACs had areas under the curves of 0.78 and 0.80, respectively.
Conclusions: Direct ALU-qPCR is a robust, highly sensitive, and high-throughput method to measure serum DNA integrity. DNA integrity is a potential serum biomarker for detection and evaluation of CRC and PACs.
Similar articles
-
Increased Free Circulating DNA Integrity Index as a Serum Biomarker in Patients with Colorectal Carcinoma.Asian Pac J Cancer Prev. 2016;17(3):939-44. doi: 10.7314/apjcp.2016.17.3.939. Asian Pac J Cancer Prev. 2016. PMID: 27039817
-
Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer.Br J Cancer. 2014 Oct 14;111(8):1482-9. doi: 10.1038/bjc.2014.470. Epub 2014 Aug 26. Br J Cancer. 2014. PMID: 25157833 Free PMC article.
-
Preoperative profiles of plasma amino acids and derivatives distinguish periampullary cancer and benign disease.BMC Cancer. 2024 May 3;24(1):555. doi: 10.1186/s12885-024-12320-8. BMC Cancer. 2024. PMID: 38702616 Free PMC article.
-
Imaging for the diagnosis and staging of periampullary carcinomas.Surg Endosc. 2003 Oct;17(10):1514-20. doi: 10.1007/s00464-002-8752-7. Epub 2003 Aug 15. Surg Endosc. 2003. PMID: 12915975 Review.
-
[Prospects of early immunocytochemical diagnosis in periampullary tumors (a review of foreign literature)].Khirurgiia (Mosk). 1995;(6):50-2. Khirurgiia (Mosk). 1995. PMID: 8569126 Review. Russian. No abstract available.
Cited by
-
Correlation between plasma ccfDNA, mtDNA changes, CTCs, and epithelial-mesenchymal transition in breast cancer patients undergoing NACT.Turk J Med Sci. 2024 Mar 11;54(4):652-665. doi: 10.55730/1300-0144.5834. eCollection 2024. Turk J Med Sci. 2024. PMID: 39295614 Free PMC article.
-
Decreased serum cell-free DNA levels in rheumatoid arthritis.Auto Immun Highlights. 2015 Aug;6(1-2):23-30. doi: 10.1007/s13317-015-0066-6. Epub 2015 Jun 27. Auto Immun Highlights. 2015. PMID: 26113482 Free PMC article.
-
DNA degradation test predicts success in whole-genome amplification from diverse clinical samples.J Mol Diagn. 2007 Sep;9(4):441-51. doi: 10.2353/jmoldx.2007.070004. Epub 2007 Aug 9. J Mol Diagn. 2007. PMID: 17690213 Free PMC article.
-
ALU repeat as potential molecular marker in the detection and prognosis of different cancer types: A systematic review.Mol Clin Oncol. 2022 Apr;16(4):86. doi: 10.3892/mco.2022.2519. Epub 2022 Feb 21. Mol Clin Oncol. 2022. PMID: 35251637 Free PMC article.
-
Serum circulating cell free DNA as potential diagnostic and prognostic biomarker in non small cell lung cancer.Biochem Biophys Rep. 2018 Jun 30;15:45-51. doi: 10.1016/j.bbrep.2018.06.002. eCollection 2018 Sep. Biochem Biophys Rep. 2018. PMID: 29984326 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical